Tuesday, November 26, 2024

Press Release: VitalTech Adds VA Growth Lead Chad Haynes to be Chief Commercial Officer

“VitalTech, a rapidly growing national provider of fully integrated health solutions, announced today Chad Haynes is joining the company as Chief Commercial Officer.”

“VitalTech has seen rapidly increasing demand for virtual care solutions to support condition management, hospital at home, aging in place, behavioral health and other strategic initiatives. As the company scales to support the growing demand for virtual care, VitalTech’s new Chief Commercial Officer will guide the company’s strategy to expand solution capabilities and ensure customer success.”

“Haynes brings more than 21 years of experience from Cerner Corporation. Most recently as Vice President for Strategic Growth, he was a member of the senior leadership team tasked with managing the company’s growth initiatives and was responsible for one of six entrepreneurial business units. In this position, he led government relations, sales, product development, deployment, support, and analytics teams across State Government & Medicaid.”

“With a deep health IT background and significant EHR experience, Haynes brings value across strategy, sales, operations, and client success.”

“Additionally, Haynes held leadership roles that led Cerner’s 10-year, $10 billion contract with the US Department of Veterans Affairs, expanded the company’s population health capabilities, managed client relationships with the 45 largest clients in the Eastern US, and resided in Singapore as Managing Director of Asia…” Read the full press release here.

Source: VitalTech Announces Chief Commercial Officer – July 7, 2021. VitalTech.

[related-post]

LEAVE A REPLY

Please enter your comment!
Please enter your name here

FedHealthIT Xtra – Find Out More!

Recent News

Don’t Miss A Thing

Jackie Gilbert
Jackie Gilbert
Jackie Gilbert is a Content Analyst for FedHealthIT and Author of 'Anything but COVID-19' on the Daily Take Newsletter for G2Xchange Health and FedCiv.

Subscribe to our mailing list

* indicates required